Byhealth Balance Sheet Health
Financial Health criteria checks 5/6
Byhealth has a total shareholder equity of CN¥11.4B and total debt of CN¥1.1B, which brings its debt-to-equity ratio to 9.5%. Its total assets and total liabilities are CN¥14.0B and CN¥2.6B respectively. Byhealth's EBIT is CN¥872.2M making its interest coverage ratio 55.2. It has cash and short-term investments of CN¥5.6B.
Key information
9.50%
Debt to equity ratio
CN¥1.08b
Debt
| Interest coverage ratio | 55.2x |
| Cash | CN¥5.65b |
| Equity | CN¥11.40b |
| Total liabilities | CN¥2.60b |
| Total assets | CN¥14.00b |
Recent financial health updates
Recent updates
Byhealth's (SZSE:300146) Weak Earnings May Only Reveal A Part Of The Whole Picture
Mar 28
Byhealth Co., Ltd (SZSE:300146) Doing What It Can To Lift Shares
Mar 10Be Wary Of Byhealth (SZSE:300146) And Its Returns On Capital
Jan 07These 4 Measures Indicate That Byhealth (SZSE:300146) Is Using Debt Reasonably Well
Dec 03Byhealth Co., Ltd (SZSE:300146) Surges 32% Yet Its Low P/E Is No Reason For Excitement
Sep 30Byhealth (SZSE:300146) Will Want To Turn Around Its Return Trends
Sep 22Things Look Grim For Byhealth Co., Ltd (SZSE:300146) After Today's Downgrade
Aug 11Investors Don't See Light At End Of Byhealth Co., Ltd's (SZSE:300146) Tunnel
Jul 26Byhealth (SZSE:300146) Could Be Struggling To Allocate Capital
May 23We Think That There Are Issues Underlying Byhealth's (SZSE:300146) Earnings
Mar 25Byhealth Co., Ltd (SZSE:300146) Just Reported Earnings, And Analysts Cut Their Target Price
Mar 23Financial Position Analysis
Short Term Liabilities: 300146's short term assets (CN¥7.5B) exceed its short term liabilities (CN¥2.4B).
Long Term Liabilities: 300146's short term assets (CN¥7.5B) exceed its long term liabilities (CN¥235.9M).
Debt to Equity History and Analysis
Debt Level: 300146 has more cash than its total debt.
Reducing Debt: 300146's debt to equity ratio has increased from 6% to 9.5% over the past 5 years.
Debt Coverage: 300146's debt is well covered by operating cash flow (116.9%).
Interest Coverage: 300146's interest payments on its debt are well covered by EBIT (55.2x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/03 16:31 |
| End of Day Share Price | 2025/11/03 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Byhealth Co., Ltd is covered by 23 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Feiyang Yuan | China International Capital Corporation Limited |
| Wenbo Chen | China International Capital Corporation Limited |
| Wendan Wang | China International Capital Corporation Limited |